An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2–dominated inflammatory response
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
In schistosomiasis, chronic parasite egg-induced granuloma formation can lead to tissue destruction and fibrosis, which causes much of the morbidity and mortality associated with this disease. Here we show the importance of IL-13 in the pathogenesis of schistosomiasis, and demonstrate, perhaps for the first time, the therapeutic efficacy of an IL-13 inhibitor, sIL-13Ralpha2-Fc, in the control of hepatic fibrosis. T-helper type 2 (Th2) cytokines dominate the immune response in mice infected with Schistosoma mansoni, yet the specific contributions of IL-13 and IL-4 to the development of fibrosis were not previously investigated. Our studies demonstrate that both cytokines play redundant roles in granuloma formation, which explains the ability of IL-4-deficient mice to form granulomas around eggs. More importantly, however, these studies demonstrate that IL-13 is the dominant Th2-type cytokine regulating fibrosis. IL-13 stimulated collagen production in fibroblasts, and procollagen I and procollagen III mRNA expression was decreased in sIL-13Ralpha2-Fc-treated mice. Moreover, the reduction in fibrosis observed in IL-4-deficient mice was much less pronounced than that in sIL-13Ralpha2-Fc-treated animals. Fibrosis is a major pathological manifestation of a number of allergic, autoimmune, and infectious diseases. Thus, our findings provide evidence that IL-13 inhibitors may be of general therapeutic benefit in preventing damaging tissue fibrosis resulting from Th2-dominated inflammatory responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-11, a member of the IL-6/gp130 cytokine family, may be one such target as it was recently shown to integrate pro-fibrotic signals emanating from both pathways146–149”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617 · cited 2×
“IL-13 was also recently shown to play a central role in murine asthma (30, 31).”
BackgroundSelf-citationRequirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Self-citationZhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719 · cited 1×
“Indeed, the targeted pulmonary expression of IL-13 was shown to cause mucus cell metaplasia, airway fibrosis, and nonspecific airway hyperreactivity (43).”
BackgroundStat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,628 · cited 1×
“In contrast to these observations, granuloma formation and the development of hepatic fibrosis was severely impaired in Stat6-deficient mice (10), which display a major defect in the production of several Th2-associated cytokines (39).”
ResultTwo Improved and Simplified Methods for the Spectrophotometric Determination of Hydroxyproline.
Bergman, I., & Loxley, R. (1963) · Analytical Chemistry · doi:10.1021/ac60205a053 · Cited by 1,525 · cited 1×
“Specifically, hepatic collagen was measured as hydroxyproline by the technique of Bergman and Loxley after hydrolysis of a 200-mg portion of liver in 5 mL of 6 N HCl at 110°C for 18 hours (35).”
MethodDisruption of the murine IL-4 gene blocks Th2 cytokine responses
Kopf, M., Gros, G. L., Bachmann, M., Lamers, M. C., Bluethmann, H., & Köhler, G. (1993) · Nature · doi:10.1038/362245a0 · Cited by 1,203 · cited 2×
“Whereas it is well known that IL-4 is the primary cytokine driving CD4+ Th2 cell development (15, 16), the role of IL-13 in the generation and maintenance of Th2-type responses remains controversial and may be influenced by both host genetics and the infectious disease model under study (24, 27, 29).”
BackgroundLe Gros, G., Ben-Sasson, S. Z., Seder, R., Finkelman, F. D., & Paul, W. E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.3.921 · Cited by 954 · cited 2×
“Whereas it is well known that IL-4 is the primary cytokine driving CD4+ Th2 cell development (15, 16), the role of IL-13 in the generation and maintenance of Th2-type responses remains controversial and may be influenced by both host genetics and the infectious disease model under study (24, 27, 29).”
BackgroundPearce, E. J., Caspar, P., Grzych, J. M., Lewis, F. A., & Sher, A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.159 · Cited by 765
Urban, J. F., Noben-Trauth, N., Donaldson, D. D., Madden, K. B., Morris, S. C., Collins, M., & Finkelman, F. D. (1998) · Immunity · doi:10.1016/s1074-7613(00)80477-x · Cited by 580
Self-citationGrzych, J. M., Pearce, E., Cheever, A., Caulada, Z. A., Caspar, P., Heiny, S., Lewis, F., & Sher, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.4.1322 · Cited by 542
Self-citation
Cited by
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
“Therapeutic implications and conclusions Studies have begun using antibodies, soluble receptors or chimaeric proteins that regulate the function of IL-13 as potential inhibitors to restrict fibrosis in granuloma formatio”
BackgroundCellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
“Indeed, a recent report suggested that TGFβ1-driven pulmonary fibrosis might in some cases be dependent on IL-13-mediated signalling through the IL-13Rα2 chain [100], which was originally thought to operate exclusively as a decoy receptor for IL-13 and as an inhibitor of fibrosis [53,101].”
BackgroundResultInfluentialSelf-citationMechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
“72), and although all three have been linked to the development of fibrosis 55,73,74 , IL-13 has emerged as a dominant mediator of fibrotic tissue remodeling in several experimental and natural models of fibrosis 74 .”
Self-citationMacrophage activation and polarization
Martinez, F. O. (2008) · Frontiers in Bioscience · doi:10.2741/2692 · Cited by 3,160
“Outside the context of type 1 and type 2 immune response paradigm macrophages have also been associated with important non pathogen-driven diseases, such as atherosclerosis (61), osteoporosis (62, 63) tissue injury and uncontrolled tissue remodeling (64-66).”
BackgroundFibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Self-citationFibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Self-citationThe pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
“Although the role of Th2 cells in the pathogenesis of hepatic [106] and pulmonary fibrosis [107] is well established, direct evidence on the involvement of Th2 cells in cardiac fibrosis is lacking.”
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456
Self-citationMacrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392
Self-citationIntegrating mechanisms of pulmonary fibrosis
Wynn, T. A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110551 · Cited by 1,274
“…mice suggest that the IL-13 signaling pathway likely serves as the dominant inducer of Th2-dependent fibrosis in several chronic lung diseases (Chiaramonte et al., 1999b; Kumar et al., 2002; Huaux et al., 2003a; Kolodsick et al., 2004; Yang et al., 2004; Lama et al., 2006; Keane et al., 2007;…”
BackgroundSelf-citationLiver fibrosis and repair: Immune regulation of wound healing in a solid organ
Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310
The immunobiology of schistosomiasis
Pearce, E. J., & MacDonald, A. S. (2002) · Nature Reviews Immunology · doi:10.1038/nri843 · Cited by 1,148
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055
Self-citationWynn, T. A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141142 · Cited by 958
Self-citationGross, T. J., & Hunninghake, G. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003200 · Cited by 962
Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
“More recently, IL- 13 has been shown to be associated with and induce tissue fibrosis ( 12 , 13, 25).”
BackgroundInfluentialHelminth parasites – masters of regulation
Maizels, R. M., Balic, A., Gomez‐Escobar, N., Nair, M., Taylor, M. D., & Allen, J. E. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00191.x · Cited by 866
“An example of this model is the decoy receptor for IL-13, a soluble competitor for cellsurface IL-13R that is able to neutralize Th2 inflammation and pathology in schistosomiasis (104, 105).”
BackgroundModels of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Iredale, J. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30542 · Cited by 866
Pulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
Self-citationArginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
Pesce, J. T., Ramalingam, T. R., Mentink-Kane, M. M., Wilson, M. S., El Kasmi, K. C., Smith, A. M., Thompson, R. W., Cheever, A. W., Murray, P. J., & Wynn, T. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000371 · Cited by 816
Self-citationHepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092121 · Cited by 730
“2, B and E), thus contrasting with the S. mansoni egg–induced fibrosis, which is highly dependent on IL4 and IL13 (Chiaramonte et al., 1999).”
BackgroundResultInfluentialSelf-citationWeirather, J., Hofmann, U. D. W., Beyersdorf, N., Ramos, G. C., Vogel, B., Frey, A., Ertl, G., Kerkau, T., & Frantz, S. (2014) · Circulation Research · doi:10.1161/circresaha.115.303895 · Cited by 699
Hesse, M., Modolell, M., La Flamme, A. C., Schito, M., Fuentes, J. M., Cheever, A. W., Pearce, E. J., & Wynn, T. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6533 · Cited by 706
“These findings suggest that the additional increase in fibrosis in DFMO-treated animals compared with that in infected, nontreated mice is unlikely to be explained by the enhanced production of type 2 cytokines (21, 26, 27).”
BackgroundSelf-citationHerbert, D. R., Hölscher, C., Mohrs, M., Arendse, B., Schwegmann, A., Radwanska, M., Leeto, M., Kirsch, R., Hall, P., Mossmann, H., et al. (2004) · Immunity · doi:10.1016/s1074-7613(04)00107-4 · Cited by 715
Interleukin‐13 in asthma pathogenesis
Wills‐Karp, M. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00215.x · Cited by 683
“mansoni infection in which sIL-13Ra2-Ig delivery completely prevented parasite-induced fibrosis (55).”
BackgroundType 2 cytokines: mechanisms and therapeutic strategies
Wynn, T. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3831 · Cited by 678
Self-citationEmerging Functions of Amphiregulin in Orchestrating Immunity, Inflammation, and Tissue Repair
Zaiss, D. M. W., Gause, W. C., Osborne, L. C., & Artis, D. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.020 · Cited by 638
“For example, IL-13 normally signals through a heterodimeric receptor composed of the IL-4Ra and IL-13Ra1 subunits, and attempts to inhibit IL-13 signaling using a soluble high-affinity IL-13Ra2 fusion protein as a decoy receptor have achieved promising results in diminishing hepatic and pulmonary fibrosis (Chiaramonte…”
BackgroundTherapy for Fibrotic Diseases: Nearing the Starting Line
Friedman, S. L., Sheppard, D., Duffield, J. S., & Violette, S. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004700 · Cited by 655
“IL-13, IL-17, and related cytokines are interesting potential targets for treatment for chronic fibrotic diseases.”
BackgroundInfluentialHost Responses in Tissue Repair and Fibrosis
Duffield, J. S., Lupher, M., Thannickal, V. J., & Wynn, T. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163930 · Cited by 624
Self-citationTerabe, M., Matsui, S., Park, J.-M., Mamura, M., Noben-Trauth, N., Donaldson, D. D., Chen, W., Wahl, S. M., Ledbetter, S., Pratt, B., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022227 · Cited by 539
Self-citationThe role of cytokines in classical Hodgkin lymphoma
Skinnider, B. F., & Mak, T. W. (2002) · Blood · doi:10.1182/blood-2002-01-0099 · Cited by 505
Raza, K., Falciani, F., Curnow, S. J., Ross, E. J., Lee, C.-Y., Akbar, A. N., Lord, J. M., Gordon, C., Buckley, C. D., & Salmon, M. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1733 · Cited by 515
Bertoletti, A., & Ferrari, C. (2012) · Gut · doi:10.1136/gutjnl-2011-301073 · Cited by 477
Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths
Gause, W. C., Wynn, T. A., & Allen, J. E. (2013) · Nature Reviews Immunology · doi:10.1038/nri3476 · Cited by 464
Self-citationHoffmann, K. F., Cheever, A. W., & Wynn, T. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6406 · Cited by 473
“1 B), consistent with previous observations (6, 33, 34).”
BackgroundResultInfluentialSelf-citationDuctular reaction in liver diseases: pathological mechanisms and translational significances
Sato, K., Marzioni, M., Meng, F., Francis, H., Glaser, S., & Alpini, G. (2019) · Hepatology · doi:10.1002/hep.30150 · Cited by 423
“(48) Inhibition of IL-13 attenuated liver fibrosis in vivo, showing the key role of IL-13 signaling in liver fibrosis.(49) These findings indicate that liver fibrosis often accompanies DR because of the close relationship between HSCs and biliary cells, and DR can occur not only in biliary disorders but also in variou…”
Macrophage Plasticity and Polarization in Liver Homeostasis and Pathology
Sica, A., Invernizzi, P., & Mantovani, A. (2014) · Hepatology · doi:10.1002/hep.26754 · Cited by 422
Fallon, P. G., Richardson, E. J., McKenzie, G. J., & McKenzie, A. N. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2585 · Cited by 403
“some infection has also been demonstrated (25).”
BackgroundCritical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity
Walter, D. M., McIntire, J. J., Berry, G., McKenzie, A. N. J., Donaldson, D. D., DeKruyff, R. H., & Umetsu, D. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4668 · Cited by 396
“in the development of hepatic fibrosis in vivo in normal mice (37), and causing the accumulation of collagen in the subepithelial layers in the lungs of mice overexpressing IL-13 (33, 34).”
BackgroundSelf-citationEvolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
Peverill, W., Powell, L., & Skoien, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058591 · Cited by 376
“Furthermore, blockade of the classic Th2 cytokine IL-13 is associated with reduced hepatic fibrosis [299].”
BackgroundTissue-specific functions of invariant natural killer T cells
Crosby, C. M., & Kronenberg, M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0034-2 · Cited by 367
Cytokine mediated tissue fibrosis
Borthwick, L. A., Wynn, T. A., & Fisher, A. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.014 · Cited by 375
“although the egg-induced inflammatory response was maintained, including no attenuation of IL-4 production [135,151,152].”
BackgroundSelf-citationIL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-β Independent
Kaviratne, M., Hesse, M., Leusink, M., Cheever, A. W., Davies, S. J., McKerrow, J. H., Wakefield, L. M., Letterio, J. J., & Wynn, T. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4020 · Cited by 370
“Because we and others have shown that IL-13 and TGF- can both bind to fibroblasts and stimulate collagen deposition (3, 5, 61), in situations where IL-13 is over-produced, the relative contribution of TGF- in fibrogenesis may be substantially diminished.”
BackgroundSelf-citationHesse, M., Piccirillo, C. A., Belkaid, Y., Prufer, J., Mentink-Kane, M., Leusink, M., Cheever, A. W., Shevach, E. M., & Wynn, T. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3157 · Cited by 369
“The Th2-associated cytokines IL-4, IL-5, and IL-13 all play important roles in the pathogenesis of schistosomiasis, with IL-4 and IL-13 directing granuloma formation (56), IL-13 as the primary stimulus for tissue fibrosis (57, 58), and IL-5 necessary for the prominent tissue eosinophil response (59, 60).”
BackgroundSelf-citationGenetic Polymorphisms and the Progression of Liver Fibrosis: A Critical Appraisal
Bataller, R., North, K. E., & Brenner, D. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50127 · Cited by 355
Origin of myofibroblasts and cellular events triggering fibrosis
Mack, M., & Yanagita, M. (2015) · Kidney International · doi:10.1038/ki.2014.287 · Cited by 342
The IL-21 receptor augments Th2 effector function and alternative macrophage activation
Pesce, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27727 · Cited by 346
“As previous studies showed that IL-4 and IL-13 are essential for lesion formation (19), we therefore hypothesized that the IL-21R was either directly or indirectly affecting the activity of these cytokines.”
BackgroundResultInfluentialImmunopathogenesis of schistosomiasis
Wynn, T. A., Thompson, R. W., Cheever, A. W., & Mentink‐Kane, M. M. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00176.x · Cited by 338
“In vitro studies demonstrated the ability of IL-13 to stimulate collagen deposition by fibroblasts (63).”
BackgroundSelf-citationFibrosis of the Lung and Other Tissues: New Concepts in Pathogenesis and Treatment
Sime, P. J., & O'Reilly, K. M. A. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5008 · Cited by 330
Lanone, S., Zheng, T., Zhu, Z., Liu, W., Lee, C. G., Ma, B., Chen, Q., Homer, R. J., Wang, J., Rabach, L. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14136 · Cited by 299
Barron, L., & Wynn, T. A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00414.2010 · Cited by 304
Self-citationImportance of Cytokines in Murine Allergic Airway Disease and Human Asthma
Finkelman, F. D., Hogan, S. P., Hershey, G. K. K., Rothenberg, M. E., & Wills-Karp, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902185 · Cited by 293
Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes
Asai, A., Miethke, A., & Bezerra, J. A. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.74 · Cited by 279
Cellular and molecular mechanisms of intestinal fibrosis
Speca, S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i28.3635 · Cited by 272
Liver fibrosis: cellular mechanisms of progression and resolution
Henderson, N. C., & Iredale, J. P. (2007) · Clinical Science · doi:10.1042/cs20060242 · Cited by 270
“Chiaramonte et al. (1999) [12] B-cells CCl4 B-cell-deficient mice Absence of B-cells attenuates liver fibrosis in an antibody- and T-cell-independent manner.”
BackgroundChiaramonte, M. G., Mentink-Kane, M., Jacobson, B. A., Cheever, A. W., Whitters, M. J., Goad, M. E. P., Wong, A., Collins, M., Donaldson, D. D., Grusby, M. J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020903 · Cited by 258
“4 B) would both exhibit IL-13R 2–inducing activity, IL-13 is likely the more important endogenous inducer simply because it is overproduced relative to IL-4 during infection (11).”
BackgroundResultInfluentialSelf-citationRecruited Monocytes and Type 2 Immunity Promote Lung Regeneration following Pneumonectomy
Lechner, A. J., Driver, I. H., Lee, J., Conroy, C. M., Nagle, A., Locksley, R. M., & Rock, J. R. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.03.024 · Cited by 256
“…macrophages and modulate their biochemical functions, including anti-inflammation, collagen synthesis, and remodeling of the extracellular matrix (Chiaramonte et al., 1999; Knipper et al., 2015; Madala et al., 2010; Martinez et al., 2009; Pellicoro et al., 2012; Pouladi et al., 2004; Zheng et…”
Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics
Liaskou, E., Zimmermann, H. W., Li, K.-K., Oo, Y. H., Suresh, S., Stamataki, Z., Qureshi, O., Lalor, P. F., Shaw, J., Syn, W.-K., et al. (2013) · Hepatology · doi:10.1002/hep.26016 · Cited by 247
“31 IL-6 promotes fibroblast proliferation, collagen production, and tissue inhibitor of metalloproteinase-1 synthesis,(32) and numerous studies in animal models demonstrate the importance of IL-13 in fibrogenesis.(33,34) It is known that infiltrating monocytes and resident macrophages play a critical role in the resol…”
BackgroundLanone, S., Zheng, T., Zhu, Z., Liu, W., Lee, C. G., Ma, B., Chen, Q., Homer, R. J., Wang, J., Rabach, L. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214136 · Cited by 248
The immune response to parasitic helminths: insights from murine models
Gause, W. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00101-7 · Cited by 247
CD4+ T Cells Mediate Abscess Formation in Intra-abdominal Sepsis by an IL-17-Dependent Mechanism
Chung, D. R., Kasper, D. L., Panzo, R. J., Chtinis, T., Grusby, M. J., Sayegh, M. H., & Tzianabos, A. O. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1958 · Cited by 246
“Wild type / 9/10 (90) CD28 / 2/10 (20) 0.”
The Schistosoma Granuloma: Friend or Foe?
Hams, E., Aviello, G., & Fallon, P. G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00089 · Cited by 233
Dual Roles of IL-4 in Lung Injury and Fibrosis
Huaux, F., Liu, T., McGarry, B., Ullenbruch, M., & Phan, S. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2083 · Cited by 236
The balancing act of the liver: tissue regeneration versus fibrosis
Cordero-Espinoza, L., & Huch, M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93562 · Cited by 219
CD4+T cells control the differentiation of Gr1+monocytes into fibrocytes
Niedermeier, M., Reich, B., Gomez, M. R., Denzel, A., Schmidbauer, K., Göbel, N., Talke, Y., Schweda, F., & Mack, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906070106 · Cited by 231
Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts
Oriente, A., Fedarko, N. S., Pacocha, S. E., Huang, S.-K., Lichtenstein, L. M., & Essayan, D. M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35380-7 · Cited by 230
“Finally, a selective inhibitor of IL-13 recently demonstrated efficacy in blocking Th2-driven hepatic fibrosis in mice infected with Schistosoma mansoni (Chiaramonte et al., 1999); a similar level of blockade was evident in wild-type and IL-4-deficient mice.”
BackgroundZheng, T., Oh, M. H., Oh, S. Y., Schroeder, J. T., Glick, A. B., & Zhu, Z. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.295 · Cited by 220
“IL-13 has been shown in different tissues as a profibrotic cytokine (Chiaramonte et al., 1999; Zhu et al., 1999; Kaviratne et al., 2004; Mentink-Kane et al., 2004).”
BackgroundIL-33 Induces IL-13–Dependent Cutaneous Fibrosis
Rankin, A. L., Mumm, J. B., Murphy, E., Turner, S., Yu, N., McClanahan, T. K., Bourne, P. A., Pierce, R. H., Kastelein, R., & Pflanz, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903306 · Cited by 216
Role of IL-13 in regulation of anti-tumor immunity and tumor growth
Terabe, M., Park, J. M., & Berzofsky, J. A. (2004) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0445-0 · Cited by 210
“Moreover, recently many IL-13-dependent, but IL-4independent or less dependent, phenomena have been reported, such as expulsion of nematode parasites [68], induction of oxazolone colitis (TH2-induced ulcerative colitis) [22], induction of asthma [20, 69], parasite-induced liver and lung fibrosis [9, 10], and other cas…”
Interleukin-5 (IL-5) Augments the Progression of Liver Fibrosis by Regulating IL-13 Activity
Reiman, R. M., Thompson, R. W., Feng, C. G., Hari, D., Knight, R., Cheever, A. W., Rosenberg, H. F., & Wynn, T. A. (2006) · Infection and Immunity · doi:10.1128/iai.74.3.1471-1479.2006 · Cited by 206
“Deletion of both IL-4 and IL-13 is necessary to markedly inhibit granuloma formation in infected animals (8, 9), while IL-13 deficiency alone significantly blocks the progression of hepatic fibrosis (7).”
BackgroundSelf-citationRetnla (Relmα/Fizz1) Suppresses Helminth-Induced Th2-Type Immunity
Pesce, J. T., Ramalingam, T. R., Wilson, M. S., Mentink-Kane, M. M., Thompson, R. W., Cheever, A. W., Urban, J. F., & Wynn, T. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000393 · Cited by 213
“mice larger at the acute time point (wk 9) they remained significantly larger than WT granulomas even after 25 weeks of infection. The chronically infected Retnla mice also displayed significant increases in hepatic fibrosis, reaching levels that were nearly 60% greater than WT mice. Given that granuloma formation and…”
BackgroundSelf-citationRegulation of extracellular matrix assembly and structure by hybrid M1/M2 macrophages
Witherel, C. E., Sao, K., Brisson, B. K., Han, B., Volk, S. W., Petrie, R. J., Han, L., & Spiller, K. L. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120667 · Cited by 212
Dynamic Mast Cell–Stromal Cell Interactions Promote Growth of Pancreatic Cancer
Ma, Y., Hwang, R. F., Logsdon, C. D., & Ullrich, S. E. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4479 · Cited by 186
“It has been identified as a dominant fibroproliferative cytokine in liver fibrosis induced by schistosomiasis as well as in pulmonary fibrosis caused by asthma via allergic mechanisms (35-37).”
BackgroundInfectious disease, the innate immune response, and fibrosis
Meneghin, A., & Hogaboam, C. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30595 · Cited by 194
“Several cytokine-based intervention studies have shown that the Th1 cytokines (102) dampen the fibrotic response, whereas the Th2 cytokines (103, 104) and chemokines (32) promote this response.”
BackgroundSkinnider, B. F. (2001) · Blood · doi:10.1182/blood.v97.1.250 · Cited by 197
Cellular and Molecular Mechanisms of Chronic Inflammation-Associated Organ Fibrosis
Ueha, S., Shand, F. H. W., & Matsushima, K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00071 · Cited by 182
Interleukin-13 Signaling and Its Role in Asthma
Rael, E. L., & Lockey, R. F. (2011) · World Allergy Organization Journal · doi:10.1097/wox.0b013e31821188e0 · Cited by 183
Schistosoma mansoni infection in eosinophil lineage–ablated mice
Swartz, J. M., Dyer, K. D., Cheever, A. W., Ramalingam, T., Pesnicak, L., Domachowske, J. B., Lee, J. J., Lee, N. A., Foster, P. S., Wynn, T. A., et al. (2006) · Blood · doi:10.1182/blood-2006-04-015933 · Cited by 185
Self-citationTh2 response polarization during infection with the helminth parasite Schistosoma mansoni
Pearce, E. J., M. Kane, C., Sun, J., J. Taylor, J., McKee, A. S., & Cervi, L. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00187.x · Cited by 189
Zhu, Z., Ma, B., Zheng, T., Homer, R. J., Lee, C. G., Charo, I. F., Noble, P., & Elias, J. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2953 · Cited by 188
“syncytial virus infection (14), hepatic fibrosis (15), and fungal pneu-”
BackgroundKolodsick, J. E., Toews, G. B., Jakubzick, C., Hogaboam, C., Moore, T. A., McKenzie, A., Wilke, C. A., Chrisman, C. J., & Moore, B. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4068 · Cited by 185
“in remodeling associated with granuloma formation (11, 12) as”
BackgroundSteiner, G. E., Stix, U., Handisurya, A., Willheim, M., Haitel, A., Reithmayr, F., Paikl, D., Ecker, R. C., Hrachowitz, K., Kramer, G., et al. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000081388.40145.65 · Cited by 185
“Constitutive IL-13 expression in lungs of mice can cause inflammation and subepithelial fibrosis (Zhu et al, 1999), and administration of IL-13 inhibitor has been shown to block hepatic fibrosis during Th2-dominated inflammatory response (Chiaramonte et al, 1999).”
BackgroundBlockade of Transforming Growth Factor-β1 Accelerates Lymphatic Regeneration during Wound Repair
Avraham, T., Daluvoy, S., Zampell, J., Yan, A., Haviv, Y. S., Rockson, S. G., & Mehrara, B. J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100594 · Cited by 181
Ramalingam, T. R., Pesce, J. T., Sheikh, F., Cheever, A. W., Mentink-Kane, M. M., Wilson, M. S., Stevens, S., Valenzuela, D. M., Murphy, A. J., Yancopoulos, G. D., et al. (2008) · Nature Immunology · doi:10.1038/ni1544 · Cited by 183
Self-citationMacrophage activation governs schistosomiasis‐induced inflammation and fibrosis
Barron, L., & Wynn, T. A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141869 · Cited by 182
Self-citationHenri, S., Chevillard, C., Mergani, A., Paris, P., Gaudart, J., Camilla, C., Dessein, H., Montero, F., Elwali, N.-E. M. A., Saeed, O. K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.929 · Cited by 184
Enhanced Interleukin (IL)-13 Responses in Mice Lacking IL-13 Receptor α 2
Wood, N., Whitters, M. J., Jacobson, B. A., Witek, J., Sypek, J. P., Kasaian, M., Eppihimer, M. J., Unger, M., Tanaka, T., Goldman, S. J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020906 · Cited by 184
“Fc is effective as an antagonist of IL-13 in vivo (6, 36).”
BackgroundSelf-citationLiver fibrosis: mechanisms of immune-mediated liver injury
Xu, R., Zhang, Z., & Wang, F.-S. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2011.53 · Cited by 183
Booth, M., Mwatha, J. K., Joseph, S., Jones, F. M., Kadzo, H., Ireri, E., Kazibwe, F., Kemijumbi, J., Kariuki, C., Kimani, G., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1295 · Cited by 178
“IL-13 has been demonstrated in mouse models to play a fundamental role in pathogenesis of fibrotic lesions associated with experimental murine schistosomiasis (21), possibly mediated by activation of the TGF- pathway (22).”
BackgroundChiaramonte, M. G., Cheever, A. W., Malley, J. D., Donaldson, D. D., & Wynn, T. A. (2001) · Hepatology · doi:10.1053/jhep.2001.26376 · Cited by 174
Self-citationBlackburn, M. R., Lee, C. G., Young, H. W. J., Zhu, Z., Chunn, J. L., Kang, M., Banerjee, S. K., & Elias, J. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16815 · Cited by 182
“In addition to regulating tissue inflammation, IL-13 is being increasingly appreciated to be a major mediator of tissue remodeling (4, 28, 30).”
BackgroundWills-Karp, M., & Chiaramonte, M. (2003) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200301000-00004 · Cited by 179
Self-citationMolecular and tissue alterations of collagens in fibrosis
Ricard-Blum, S., Baffet, G., & Théret, N. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.004 · Cited by 173
Strategies for anti-fibrotic therapies
Rosenbloom, J., Mendoza, F. A., & Jimenez, S. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.007 · Cited by 170
“The TH2 profibrotic responses, are characterized most importantly by the production of IL-13, which has been shown to be a potent stimulator of fibroblast proliferation and collagen production and when overexpressed induced skin and lung fibrosis in various experimental models [231].”
BackgroundKumar, R. K., Herbert, C., Yang, M., Koskinen, A. M. L., McKenzie, A. N. J., & Foster, P. S. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2002.01420.x · Cited by 168
Ryzhov, S., Goldstein, A. E., Matafonov, A., Zeng, D., Biaggioni, I., & Feoktistov, I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7726 · Cited by 169
Corne, J., Chupp, G., Lee, C. G., Homer, R. J., Zhu, Z., Chen, Q., Ma, B., Du, Y., Roux, F., McArdle, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9674 · Cited by 166
“IL-13 is a potent stimulator of tissue inflammation, airway fibrosis, and alveolar remodeling in our transgenic mice and other in vivo systems (30, 37, 38).”
BackgroundMadala, S. K., Pesce, J. T., Ramalingam, T. R., Wilson, M. S., Minnicozzi, S., Cheever, A. W., Thompson, R. W., Mentink-Kane, M. M., & Wynn, T. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903008 · Cited by 162
“mansoni eggs (6, 8), with IL-13Ra1 inducing and the decoy IL-13Ra2 suppressing the development of fibrosis (26, 27).”
BackgroundResultInfluentialSelf-citationRegulation of allergy and autoimmunity in helminth infection
Wilson, M. S., & Maizels, R. M. (2004) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:26:1:35 · Cited by 163
Metadata
- Authors
- Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Biomedical Research Institute (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 777-785
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408441
- OpenAlex
- W1975021657
- Cited by
- 603
- References
- 47
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 7 · 2023: 8 · 2022: 14 · 2021: 16 · 2020: 21 · 2019: 13 · 2018: 34 · 2017: 18 · 2016: 30 · 2015: 28 · 2014: 35 · 2013: 23 · 2012: 30
- FWCI
- 19.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-13, liver fibrosis, schistosomiasis, Schistosoma mansoni, Th2 cytokines, IL-4, granuloma formation, collagen synthesis, fibroblasts, procollagen mRNA, antifibrotic therapy
- MeSH terms
- Animals, Female, Liver, Liver Cirrhosis, Experimental, Mice, Inbred C57BL, Procollagen, RNA, Messenger, Schistosomiasis mansoni, Interleukin-4, Cytokines, 3T3 Cells, Mice, Knockout, Th1 Cells, Th2 Cells, Interleukin-13, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.